解剖性肝切除术前胆道支架置入后持续高胆红素血症预测严重并发症
基于ACS-NSQIP 2016-2021数据库,纳入463例术前胆道引流后行解剖性肝切除的胆管癌患者,217例(46.9%)引流后仍存在高胆红素血症(>1.2 mg/dL)。多因素分析显示持续高胆红素血症与严重并发症(OR 1.88,P=0.020)和死亡率(OR 2.39,P=0.049)独立相关,但与术后肝衰竭无独立关联(OR 1.65,P=0.082)。
要点
- 术前胆道引流后持续高胆红素血症(>1.2 mg/dL)发生率为46.9%(217/463)。
- 持续高胆红素血症组严重并发症发生率80.7%,高于非高胆红素血症组的70.3%(P=0.010)。
- 持续高胆红素血症与严重并发症(OR 1.88)和死亡率(OR 2.39)独立相关。
核心结论
- 术前胆道减压失败是肝切除患者术后并发症和死亡率的预测因素,可能有助于术前风险分层。
研究设计与样本
- 回顾性数据库研究,使用ACS-NSQIP(2016-2021)数据,纳入463例接受术前胆道引流的胆管癌并行解剖性肝切除的患者。
主要发现
- 217例(46.9%)在胆道支架置入后仍存在高胆红素血症(>1.2 mg/dL)。
- 高胆红素血症组严重并发症发生率80.7%,非高胆红素血症组70.3%(P=0.010)。
- 高胆红素血症组胆漏发生率40.9%,非高胆红素血症组31.8%(P=0.045)。
- 高胆红素血症组肝衰竭发生率26.7%,非高胆红素血症组17.9%(P=0.022)。
- 高胆红素血症组出血发生率48.4%,非高胆红素血症组36.6%(P=0.010)。
关键数值与推荐
- 高胆红素血症定义为术前胆道引流后总胆红素>1.2 mg/dL。
- 严重并发症多因素分析OR 1.88(P=0.020)。
- 死亡率多因素分析OR 2.39(P=0.049)。
- 术后肝衰竭多因素分析OR 1.65(P=0.082)。
临床怎么用
- 术前胆道引流后持续高胆红素血症可能有助于对肝切除患者进行术前风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biliary obstruction before liver resection is a known risk factor for post-operative complications. The aim of this study was to determine the impact of persistent hyperbilirubinemia following preoperative biliary drainage before liver resection. METHODS: The ACS-NSQIP (2016-2021) database was used to extract patients with cholangiocarcinoma who underwent anatomic liver resection with preoperative biliary drainage comparing those with persistent hyperbilirubinemia (> 1.2 mg/dL) to those with resolution. Patient characteristics and outcomes were compared with bivariate analysis. Multivariable modeling evaluated factors including persistent hyperbilirubinemia to evaluate their independent effect on serious complications, liver failure, and mortality. RESULTS: We evaluated 463 patients with 217 (46.9%) having hyperbilirubinemia (HB) despite biliary stenting. Bivariate analysis demonstrated that patients with HB had a higher rate of serious complications than those with non-HB (80.7% vs 70.3%; P = 0.010) including bile leak (40.9% vs 31.8%; P = 0.045), liver failure (26.7% vs 17.9%; P = 0.022), and bleeding (48.4% vs 36.6%; P = 0.010). Multivariable analysis demonstrated that persistent HB was independently associated with serious complications (OR 1.88, P = 0.020) and mortality (OR 2.39, P = 0.049) but not post-operative liver failure (OR 1.65, P = 0.082). CONCLUSIONS: Failed preoperative biliary decompression is a predictive factor for post-operative complications and mortality in patients undergoing hepatectomy and may be useful for preoperative risk stratification.
引用
- Kirkland M, Verhoeff K, Jogiat U, et al. Persistent hyperbilirubinemia following preoperative biliary stenting in patients undergoing anatomic hepatectomy predicts serious complications. Surg Endosc. 2024. PMID: 38872019. doi:10.1007/s00464-024-10968-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。